Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 33465
Evènement :Allogeneic Cell Therapies Summit Europe

Dates :Mardi 18 Janvier 2022 - Jeudi 20 Janvier 2022

Lieu :Amba Marble Arch (Guoman)
Bryanston Street
W1H 7EH Greater London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--




Address Key European Regulatory Challenges and Cutting Edge Platform Design to Advance Allogeneic Approaches
Allogeneic therapies are fast becoming the holy grail for cell therapy as they boast the potential to reduce the cost of goods, improve accessibility, reduce turnaround times and have the ability to treat masses of patients. However, in Europe there are critical challenges limiting clinical advancement, with increased complexities with disharmonized European regulations where guidance varies across countries, and challenges in cross-country logistics when running multicentric trials.
The Allogeneic Cell Therapies Summit Europe is the only industry-focused forum dedicated to address the specific challenges facing European drug developers in order to advance your pipeline to clinical and commercial success.
Collaborate with European leaders from Cellectis, Celyad, GammaDelta Therapeutics, Medicines and Healthcare Products Regulatory Agency and more to benchmark best-in-class approaches to achieve optimal clinical set up and large scale manufacture for your off-the-shelf product. Ensure you have these important considerations planned early in development to overcome delays and critical push backs later in your clinical translation.
Join your community in London this January to take on this next frontier in cell therapy and leave with cutting-edge strategies to develop safe, effective and accessible cell therapies for patients in Europe.
This is your comprehensive guide to define your commercial path forward developing off-the-shelf products.
18-20 January, 2022
London, UK
Brochure https://go.evvnt.com/925458-0?pid=4319
Tickets https://go.evvnt.com/925458-1?pid=4319
Website https://go.evvnt.com/925458-3?pid=4319
Drug Developers (Earlybird rates & workshops available) GBP 2599.00
Academic (Earlybird rates & workshops available) GBP 2099.00
Service Providers (Earlybird rates & workshops available) GBP 2999.00
Speakers: Miguel Forte, CEO, Bone Therapeutics, André Choulika, CEO, Cellectis, Vicki Coutinho, VP of Regulatory Affairs & Quality, GammaDelta Therapeutics, Troels Jordansen, CEO, Glycostem Therapeutics, Kimberly Schluns, Senior Director, Research, Kite Pharma, John Johnston, Clinical Assessor, MHRA
Date and Time: Starts: Tue, Jan 18, 2022 ( 8:00 AM) and Ends: Thu, Jan 20, 2022 ( 6:00 PM)


Plan et itinéraire
Adresse de la conférence :
Amba Marble Arch (Guoman)
Bryanston Street
W1H 7EH Greater London
Plan et itinéraire


Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama


Allogeneic Cell Therapies Summit Europe Médecine
allogeneic, allogeneicapproaches, allogeneictherapies
Tout public
-- -- --


Pour plus d'informations sur Allogeneic Cell Therapies Summit Europe, veuillez contacter Hanson Wade

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama

Recommander cet évènement